Dr. Wenhong Cao, assistant investigator in the Division of Translational Biology at The Hamner Institutes for Health Sciences, has been awarded $1.6 million from the National Institutes of Health to perform diabetes research over five years.
The grant will allow Cao to study new biochemical pathways of how the body maintains sugar balance and its relationship to weight regulation. This research is part of The Hamner's expanding program in diabetes and cardiovascular disease.
"This grant is a tremendous opportunity to strengthen our research in metabolic and cardiovascular disease," said Dr. William F. Greenlee, president and CEO of The Hamner Institutes. "Diabetes is a major public health issue, and we are excited to see the impact Dr. Cao's work will have on fighting this disease."
About The Hamner Institutes for Health Sciences:
Located on a 56-acre campus in Research Triangle Park, N.C., The Hamner Institutes is an independent, nonprofit organization that unites academia, the private sector and government to conduct translational research to improve public health and expedite the development of new medicines.
With the ultimate goal of preventing and curing disease, The Hamner offers an open, collaborative and cross-disciplinary approach to strengthen the research investment in biomedical sciences.
CIIT, the flagship institute for The Hamner, has been recognized for more than 30 years as a leader in research in environmental risk assessment and health sciences.